by cmooney67 | July 27, 2017 10:30 am
Brace yourself…
What you are about to witness will floor you.
In short, a renegade group of Harvard scientists has made a discovery so TRANSFORMATIVE, Bloomberg[1] calls it ”the discovery of the century that will change the world.”
As you will see, this mind-blowing breakthrough will touch your life in a profound and personal way.
At the same time, it could hand you a staggering financial windfall, the likes of which only come around once in a generation.
In fact, the tiny $6 million start-up behind this innovation is holding 40 registered patents and is on the cusp of an explosive 28,700% sales-surge.
But time is of the essence…
An imminent announcement is expected, and savvy Wall Street insiders have already grabbed up 80% of available shares.
In fact, Citigroup frantically boosted their positon by a whopping 1,400%, and this deal could close out as early as tomorrow’s opening bell.
For details, go here fast…
You’ll be so glad you did…
Sincerely,
Mike Ward[2]
Publisher, Money Map Press[3]
Source URL: https://www.stockgumshoe.com/2017/07/microblog-any-analysis-on-the-money-map-press-latest-tease-rogue-scientists-technological-hack-caught-on-video/
Copyright ©2024 Stock Gumshoe unless otherwise noted.
So I just read the teaser. If it’s true it could be something worth taking a serious look at.
any ideas about the company touted?
What’s the name of the company?
the teaser reminded me of the blcm debacle they were pushing recently, lost some $$ on that one. I dont trust the huge windfall profits they promote anymore.
There latest tease is the CODE OF LIFE.
interested as well and not interested in dropping $1,900 to find out if its BS
Never give MMP ANY money
I read the teaser also. Has anyone figured out what company this is? Not dropping this amount on ANOTHER newsletter!!
I think the company is Editas
I agree. In fact, I talked a week ago to a guy with Money Map Press, and he said the stock, which he of course didn’t name, had closed up at $16 that day. I checked Editas, and it closed at $17. But I think the guy just made a small mistake. I read stuff about gene-editing and this big patent controversy, and Editas seems to be the only company it could be. But I’m very possibly wrong.
I also did some research and Editas fits the bill. however Editas is $One Billion company at $28 a share. money guys claiming their company is a tiny $6 million…
The $6 million is their sales number, not the market cap. Disingenuous because sales are currently meaningless for the company, but technically true.
He is teasing it heavily today suggesting tomorrow there will be an announcement that will shoot this stock up ” on the verge of an epic 28,700% sales surge. ” ..? Do you know what it is ?
Need Travis on the case.
This company was heavily teased 2 years ago, when they apparently thought that the patent fight in court would be over quickly [or they thought they could convince us of that]. This is all about rights to the gene-editing technique known as CRISPR. So this is a lab biochemical technique, and I can guarantee you, from a practical perspective these patents WILL BE INFRINGED mercilessly, because there’s almost no way they could be enforced. So while this technique will, indeed, almost certainly change the world, the changes are unpredictable, many likely catastrophically bad, and certainly are unlikely to devolve from a single company just because of the patent portfolio.
Devices are relatively easy to enforce regarding patents. You can buy the device, reverse engineer it, and prove that the seller infringed your patent. But this biochemical process for editing nucleic acid sequences in cells is a momentary phenomenon – after I do it, you can’t even prove that I did it. Good luck proving that I infringed your patent. Now if this tiny company had pockets as deep as let’s say – AAPL? – then they might have the scratch to pursue infringers, but a company this small won’t be able to do a thing.
Caveat emptor.
Maddogne – Thanks for your good memory and quick feedback, another money map press to dismiss.
my gut tells me it could be a one of these but Travis or others could help pin point. Editas, (edit) Cymabay (cbay) Intellia (ntla) or CRISPR THERAPEUTICS AG (crsp)n the discussion
Ah, Maddogne sounds like he knows what he’s talking about.
there are several companies doing ”gene editing”. CRISPR is one.
EDIT at Cambridge Mass. ?? Please verify.
so my gut tells me it could be a one of these but Travis or others could help pin point. Editas, (edit) Cymabay (cbay) Intellia (ntla) or CRISPR THERAPEUTICS AG (crsp)
crsp would be my guess
They are now saying “mainstream media” is all over this so need to hurry. Had it not been for that statement I would want to buy today and sell on the day before the big announcement for a small skim. But of course I am not sure who the company is as I have not seen the mainstream reports . Buy into the hype and sell on the news . Probably to late for that now .
I posted my answers on a related BLOG several days ago. Only one company fits all the criteria described by Mr. Robinson: https://www.stockgumshoe.com/2017/07/microblog-the-code-of-life/
how do these hype companies really make their money?
how do these hype companies really make their money?